Trials / Completed
CompletedNCT00141050
Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 90 (planned)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 6 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Focalin XR |
Timeline
- Start date
- 2005-05-01
- Completion
- 2005-07-01
- First posted
- 2005-09-01
- Last updated
- 2007-12-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00141050. Inclusion in this directory is not an endorsement.